KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Current Assets (2016 - 2025)

Historic Current Assets for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $6.4 billion.

  • Edwards Lifesciences' Current Assets fell 548.18% to $6.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 billion, marking a year-over-year decrease of 548.18%. This contributed to the annual value of $6.3 billion for FY2024, which is 5574.5% up from last year.
  • Edwards Lifesciences' Current Assets amounted to $6.4 billion in Q3 2025, which was down 548.18% from $6.6 billion recorded in Q2 2025.
  • Edwards Lifesciences' 5-year Current Assets high stood at $6.7 billion for Q3 2024, and its period low was $3.1 billion during Q1 2021.
  • In the last 5 years, Edwards Lifesciences' Current Assets had a median value of $3.6 billion in 2023 and averaged $4.3 billion.
  • Its Current Assets has fluctuated over the past 5 years, first soared by 6540.14% in 2024, then plummeted by 548.18% in 2025.
  • Over the past 5 years, Edwards Lifesciences' Current Assets (Quarter) stood at $3.2 billion in 2021, then decreased by 2.67% to $3.1 billion in 2022, then soared by 30.36% to $4.0 billion in 2023, then surged by 55.74% to $6.3 billion in 2024, then increased by 1.17% to $6.4 billion in 2025.
  • Its Current Assets stands at $6.4 billion for Q3 2025, versus $6.6 billion for Q2 2025 and $6.2 billion for Q1 2025.